Bahram Valamehr

2018

In 2018, Bahram Valamehr earned a total compensation of $2.6M as Chief Development Officer at Fate Therapeutics.

Compensation breakdown

Non-Equity Incentive Plan$117,250
Option Awards$2,138,235
Salary$321,865
Total$2,577,350

Valamehr received $2.1M in option awards, accounting for 83% of the total pay in 2018.

Valamehr also received $117.3K in non-equity incentive plan and $321.9K in salary.

Rankings

In 2018, Bahram Valamehr's compensation ranked 4,541st out of 14,244 executives tracked by ExecPay. In other words, Valamehr earned more than 68.1% of executives.

ClassificationRankingPercentile
All
4,541
out of 14,244
68th
Division
Manufacturing
1,703
out of 5,765
71st
Major group
Chemicals And Allied Products
614
out of 2,128
71st
Industry group
Drugs
514
out of 1,817
72nd
Industry
Biological Products, Except Diagnostic Substances
101
out of 339
70th
Source: SEC filing on March 22, 2019.

Valamehr's colleagues

We found three more compensation records of executives who worked with Bahram Valamehr at Fate Therapeutics in 2018.

2018

J Wolchko

Fate Therapeutics

Chief Executive Officer

2018

Cindy Tahl

Fate Therapeutics

General Counsel

2018

Daniel Shoemaker

Fate Therapeutics

Chief Scientific Officer

News

In-depth

You may also like